Target N V Biotech's Net Worth
-$9.57 Million
Who is Target N V Biotech?
Target N V Biotech does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include MACROGENICS INC, Esperion Therapeutics, Inc., Cidara Therapeutics, Inc., Molecular Templates, Inc., Radius Health, Inc., and VIROLOGIC INC.
SEC CIK
Target N V Biotech's CIK is 0001259870
Past Insider Trading and Trends
2021 was Target N V Biotech's most active year for acquiring shares with 35 total transactions. Target N V Biotech's most active month to acquire stocks was the month of March. 2003 was Target N V Biotech's most active year for disposing of shares, totalling 1 transactions. Target N V Biotech's most active month to dispose stocks was the month of July. 2021 saw Target N V Biotech paying a total of $80,578,431.98 for 6,441,672 shares, this is the most they've acquired in one year. In 2022 Target N V Biotech cashed out on 8,733,538 shares for a total of $87,335,380.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
MACROGENICS INC (MGNX) Snapshot price: $3.1701
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +1.53% | 150K |
$4.46 | $669,585.00 | 9.93M |
Oct 2
| |||
Form 4
| +2.09% | 200K |
$5.26 | $1,052,840.00 | 9.78M |
Sep 7
| |||
Form 4
| +5.51% | 500K |
$5.07 | $2,532,600.00 | 9.58M |
Feb 14
| |||
Form 4
| +1.68% | 150K |
$5.30 | $794,925.00 | 9.08M |
Jan 19
| |||
Form 4
| +4.69% | 400K |
$5.75 | $2,298,600.00 | 8.93M |
Dec 23 - Dec 27
| |||
Form 4
| +3.65% | 300K |
$5.96 | $1,788,180.00 | 8.53M |
Nov 22
| |||
Form 4
| +6.47% | 500K |
$4.50 | $2,247,600.00 | 8.23M |
Oct 21 - Oct 24
| |||
Form 4
| +6.25% | 454.4K |
$3.89 | $1,767,484.13 | 7.73M |
Oct 19 - Oct 20
| |||
Form 4
| +2.83% | 200K |
$18.50 | $3,700,320.00 | 7.28M |
Nov 19
| |||
Form 4
| +2.91% | 200K |
$20.56 | $4,111,420.00 | 7.08M |
Sep 28 - Sep 29
| |||
Form 4
| +9.56% | 600K |
$20.61 | $12,363,480.00 | 6.88M |
Sep 16 - Sep 17
| |||
Form 4
| +1.21% | 75K |
$21.74 | $1,630,170.00 | 6.28M |
Jun 21
| |||
Form 4
| +2.90% | 175K |
$20.82 | $3,644,005.00 | 6.2M |
Jun 15 - Jun 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Esperion Therapeutics, Inc. (ESPR) Snapshot price: $1.69
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +2.28% | 100K |
$20.22 | $2,021,620.00 | 4.48M |
May 24
| |||
Form 4
| +4.79% | 200K |
$20.37 | $4,073,960.00 | 4.38M |
May 19
| |||
Form 4
| +5.83% | 230K |
$20.21 | $4,648,482.00 | 4.18M |
May 5 - May 6
| |||
Form 4
| +5.34% | 200K |
$25.31 | $5,062,120.00 | 3.95M |
Nov 3
| |||
Form 4
| +0.54% | 20K |
$52.12 | $1,042,398.00 | 3.75M |
Jan 23
| |||
Form 4
| +2.05% | 75K |
$37.30 | $2,797,560.00 | 3.73M |
Nov 6
| |||
Form 4
| +2.24% | 80K |
$33.78 | $2,702,208.00 | 3.65M |
Sep 4
| |||
Form 4
| +1.42% | 50K |
$42.65 | $2,132,565.00 | 3.57M |
Jul 23
| |||
Form 4
| +1.44% | 50K |
$49.89 | $2,494,355.00 | 3.52M |
Mar 14
| |||
Form 4
| +2.36% | 80K |
$41.29 | $3,303,256.00 | 3.47M |
Jan 4
| |||
Form 4
| +1.50% | 50K |
$39.91 | $1,995,725.00 | 3.39M |
Dec 24
| |||
Form 4
| +1.83% | 60K |
$47.73 | $2,864,070.00 | 3.34M |
Dec 17
| |||
Form 4
| +1.55% | 50K |
$46.14 | $2,306,970.00 | 3.28M |
Aug 3
| |||
Form 4
| +1.57% | 50K |
$41.77 | $2,088,300.00 | 3.23M |
Jul 12
| |||
Form 4
| +1.60% | 50K |
$39.48 | $1,973,805.00 | 3.18M |
Jun 29
| |||
Form 4
| +1.95% | 60K |
$38.57 | $2,314,224.00 | 3.13M |
Jun 21
| |||
Form 4
| +1.99% | 60K |
$37.79 | $2,267,292.00 | 3.07M |
Jun 7
| |||
Form 4
| +2.03% | 60K |
$38.47 | $2,308,440.00 | 3.01M |
Jun 5
| |||
Form 4
| +4.61% | 130K |
$40.11 | $5,213,770.00 | 2.95M |
May 18 - May 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Cidara Therapeutics, Inc. (CDTX) Snapshot price: $13
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +2.68% | 60K |
$7.57 | $453,966.00 | 2.3M |
Nov 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Molecular Templates, Inc. (MTEM) Snapshot price: $1.53
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +24.28% | 250K |
$2.35 | $587,500.00 | 1.28M |
Apr 2
| |||
Form 4
| +38.02% | 4.26M |
$0.47 | $1,999,999.93 | 15.45M |
Jul 17
| |||
Form 4
| +1.82% | 200K |
$1.18 | $236,200.00 | 11.19M |
May 16
| |||
Form 4
| +1.85% | 200K |
$4.04 | $807,180.00 | 10.99M |
Jan 6
| |||
Form 4
| +7.47% | 750K |
$6.00 | $4,500,000.00 | 10.79M |
Sep 21
| |||
Form 4
| +1.01% | 100K |
$6.13 | $613,000.00 | 10.04M |
Sep 16
| |||
Form 4
| +1.58% | 155K |
$7.04 | $1,091,656.00 | 9.94M |
Jul 26 - Jul 27
| |||
Form 4
| +2.56% | 244.38K |
$7.05 | $1,722,502.09 | 9.79M |
Jul 19 - Jul 20
| |||
Form 4
| +0.43% | 40.85K |
$8.08 | $329,941.18 | 9.54M |
Apr 19
| |||
Form 4
| +1.60% | 150K |
$8.62 | $1,292,655.00 | 9.5M |
Apr 15
| |||
Form 4
| +2.75% | 250K |
$8.15 | $2,037,010.00 | 9.35M |
Apr 13 - Apr 14
| |||
Form 4
| +3.24% | 285.66K |
$8.19 | $2,340,462.55 | 9.1M |
Apr 9 - Apr 12
| |||
Form 4
| +6.01% | 500K |
$8.23 | $4,114,820.00 | 8.82M |
Apr 7 - Apr 8
| |||
Form 4
| +2.46% | 200K |
$9.44 | $1,887,100.00 | 8.32M |
Apr 5
| |||
Form 4
| +1.00% | 80K |
$11.45 | $915,848.00 | 8.12M |
Mar 29
| |||
Form 4
| +4.01% | 310K |
$11.33 | $3,513,865.66 | 8.04M |
Feb 23 - Feb 24
| |||
Form 4
| +18.13% | 1.19M |
$12.65 | $14,999,990.50 | 7.73M |
Feb 18
| |||
Form 4
| +1.24% | 80K |
$11.69 | $935,344.00 | 6.54M |
Feb 1
| |||
Form 4
| +1.25% | 80K |
$11.94 | $955,000.00 | 6.46M |
Jan 29
| |||
Form 4
| +7.50% | 445K |
$8.38 | $3,727,441.00 | 6.38M |
Dec 9 - Dec 10
| |||
Form 4
| +2.77% | 160K |
$9.10 | $1,456,616.00 | 5.94M |
Nov 9 - Nov 10
| |||
Form 4
| +10.43% | 545.34K |
$8.68 | $4,734,190.02 | 5.78M |
Nov 5 - Nov 6
| |||
Form 4
| +3.16% | 160K |
$9.11 | $1,458,000.00 | 5.23M |
Oct 28 - Oct 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Radius Health, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -8.73M |
$10.00 | -$87,335,380.00 |
0
|
Aug 11
| |||
Form 4
| +5.79% | 477.82K |
$5.57 | $2,661,001.86 | 8.73M |
May 18
| |||
Form 4
| +7.14% | 550K |
$6.31 | $3,469,060.00 | 8.26M |
Jan 5 - Jan 6
| |||
Form 4
| +1.31% | 100K |
$12.95 | $1,294,500.00 | 7.71M |
Sep 29
| |||
Form 4
| +2.01% | 150K |
$12.28 | $1,841,280.00 | 7.61M |
Sep 22
| |||
Form 4
| +1.36% | 100K |
$14.26 | $1,426,230.00 | 7.46M |
Nov 5
| |||
Form 4
| +2.79% | 200K |
$11.69 | $2,338,680.00 | 7.36M |
Sep 14
| |||
Form 4
| +2.86% | 199.03K |
$11.33 | $2,255,117.99 | 7.16M |
Sep 11
| |||
Form 4
| +0.36% | 25K |
$13.21 | $330,177.50 | 6.96M |
Jul 8
| |||
Form 4
| +0.73% | 50K |
$15.75 | $787,555.00 | 6.93M |
Apr 30
| |||
| No matching records found | |||||||||